MYCN and neuroblastoma: According to the age at the time of tumor diagnosis, histopathological type, International Neuroblastoma Staging System stage, the presence or the absence of MYCN oncogene amplification, and tumor DNA index, NB can be classified into low-, intermediate-, and high-risk groups, which can be used to guide subsequent treatment and evaluate prognosis (2).